Professor Irit Ben-Aharon
Oncologist. A well-known oncologist and one of the best specialists in the world in treating gastrointestinal cancers; director of the GI Oncology Company at the Davidoff Center at Beilinson Hospital. She also has a private practice. 15 years of experience.
Professor Irit Ben-Aharon graduated from the medical university in Tel Aviv, where she also earned a second doctorate in embryonic biology and fertility.
Fellowships:
- 2010-2011 at the Dana-Farber Cancer Institute, Boston, USA, in oncofertility,
- 2014-2015 at Memorial Sloan Kettering Cancer Center (MSKCC), New York, USA, in gastrointestinal malignancies.
Irit Ben-Aharon also received postdoctoral training at the National Institutes of Health in the USA in developmental biology and fertility.
Membership in professional organizations:
- ISCORT: Israeli Society of Clinical Oncology and Radiotherapy.
- ASCO: American Society of Clinical Oncology
- AACR: American Association for Cancer Research
Today Professor Ben-Aharon heads the GI oncology company at the Davidoff Center at Beilinson Hospital, is an associate professor, and teaches at the Faculty of Medicine of Tel Aviv University. She also leads clinical studies of gastrointestinal neoplasms in young people and studies the side effects of chemotherapy in collaboration with research groups in Israel and the USA. She is a regular honored guest at conferences on the treatment of gastrointestinal cancers. Over the years she has received prestigious scientific awards and research grants in Israel and abroad.
Professor Ben-Aharon's research focuses on oncology of the digestive system, as well as oncology at a young age: both in terms of biology and in terms of the consequences of conventional treatment for the body.
Professor Ben-Aharon is a member of the Israeli Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology and the American Association for Cancer Research.
- Pancreatic cancer
- Stomach cancer
- Esophageal cancer
- Colorectal cancer
- Oncology of all organs of the hepatobiliary system
- Cholangiocarcinoma
To treat patients, Professor Ben-Aharon successfully uses the latest biological drugs, targeted therapy and personalized medicine tools (for example, molecular DNA analysis to select individual treatment for each patient).